Articles

Commercial disease management models did not reduce hospital admissions or emergency room visits, or result in cost savings in a study of nearly 250,000 Medicare patients.…

An FDA advisory committee has recommended unanimously that the ezetimibe-simvastatin combination pill (Vytorin) be approved for prevention of cardiovascular disease in CKD patients who are not on dialysis.…

Dapagliflozin, an inhibitor of SGLT2 as an adjunct to diet and exercise, is being investigated to evaluate its safety and its efficacy on blood sugar levels in adults with type 2 diabetes….

Although the pharmacokinetics and pharmacodynamics of high-dose human regular U-500 and human regular U-100 insulin are similar, the U-500 formulation may have a longer duration of action.…

Erectile dysfunction has traditionally been associated with vascular problems, but men with severe peripheral neuropathy frequently reported ED as well as failure with phosphodiesterase type-5 inhibitors.…

State bans on sugar-sweetened drinks in middle schools didn’t have much impact on kids’ overall consumption.…

Intensive blood glucose control won’t reduce the risk of heart failure in patients with type 2 diabetes — and tight control using a thiazolidinedione may actually increase the risk….

Insulin delivery with a closed-loop system was at least as effective as continuous subcutaneous insulin infusion in a UK study of pregnant women with type 1 diabetes.…

They announced an agreement to terminate their alliance for exenatide and resolve the outstanding litigation between the companies….

Adipotide basically reduces the blood supply specifically to fat cells, causing them to simply wither away.…